Search Results - "Unit, Liver"

Correspondence to editorial on “Macrophage ATG16L1 expression suppresses metabolic dysfunction-associated steatohepatitis progression by promoting lipophagy” by Wang, Qi, Bu, Qingfa, Zhou, Haoming, Lu, Ling

“…[...]inflammation of visceral adipose tissues was decreased in macrophages of Atg16l1 knockout MASH mice as compared to floxed MASH mice. [...]we found that…”
Get full text

Clinical criteria are critical to diagnosing alcoholic hepatitis by Forrest, Ewan

Get full text

Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment by Sogbe, Miguel, Bilbao, Idoia, Marchese, Francesco P, Zazpe, Jon, De Vito, Annarosaria, Pozuelo, Marta, D'Avola, Delia, Iñarrairaegui, Mercedes, Berasain, Carmen, Arechederra, Maria, Argemi, Josepmaria, Sangro, Bruno

“…New prognostic markers are needed to identify patients with hepatocellular carcinoma (HCC) who carry a worse prognosis. Ultra-low-pass whole-genome sequencing…”
Get full text

Hepatitis C virus cures after direct acting antiviral-related drug-induced liver injury: Case report by Hasin, Yaakov, Shteingart, Shimon, Dahari, Harel, Gafanovich, Inna, Floru, Sharon, Braun, Marius, Shlomai, Amir, Verstandig, Anthony, Dery, Ilana, Uprichard, Susan L, Cotler, Scott J, Lurie, Yoav

“…The United States Food and Drug Administration recently warned that the direct acting antiviral(DAA) combination hepatitis C virus(HCV) treatment of…”
Get full text

Receipt of Curative Resection or Palliative Care for Hepatopancreaticobiliary Tumours (RICOCHET): Protocol for a Nationwide Collaborative Observational Study by The RICOCHET Study Group 1, West Midlands Research Collaborative 1

“…There are variations in the management of patients with suspected pancreatic and periampullary cancers and/or malignant biliary obstruction. These differences…”
Get full text

Hepatic Angiomyolipoma: a Rarely Described Tumor by Griñó, Pilar, Such, José, Unit, Liver

Get full text

A new strategy to identify hepatitis B virus entry inhibitors by AlphaScreen technology targeting the envelope-receptor interaction by Saso, Wakana, Tsukuda, Senko, Ohashi, Hirofumi, Fukano, Kento, Morishita, Ryo, Matsunaga, Satoko, Ohki, Mio, Ryo, Akihide, Park, Sam-Yong, Suzuki, Ryosuke, Aizaki, Hideki, Muramatsu, Masamichi, Sureau, Camille, Wakita, Takaji, Matano, Tetsuro, Watashi, Koichi

“…Current anti-hepatitis B virus (HBV) agents have limited effect in curing HBV infection, and thus novel anti-HBV agents with different modes of action are in…”
Get full text